This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Qi Chen - Innovator in Cancer Treatment
Introduction
Qi Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on inhibitors of AKT activity, which play a crucial role in cancer therapy.
Latest Patents
Qi Chen holds a patent for "Inhibitors of AKT activity." This invention provides substituted fused pyrimidine compounds of Formula A that inhibit Akt activity. The compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also includes compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of cancer treatment. He has 1 patent to his name.
Career Highlights
Qi Chen is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in the pharmaceutical industry. His work has the potential to impact cancer treatment significantly, providing new avenues for therapy.
Collaborations
Some of his coworkers include Mingxiang Cui and Bin Hu, who contribute to the collaborative efforts in their research projects.
Conclusion
Qi Chen's innovative work in developing AKT inhibitors showcases his commitment to improving cancer treatment options. His contributions to the field are invaluable and highlight the importance of research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile